ViCardia Therapeutics, Inc. — Form D

ViCardia Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-21. The offering totals $700K, of which $700K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-05-21
• Form: D
• Accession: 0002135564-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $700K
• Amount sold: $700K
• Minimum investment: $10K
• Investors: 1
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-584772

Issuer

• Name: ViCardia Therapeutics, Inc.
• CIK: 0002135564
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 530 BUSH STREET, SUITE 802, SAN FRANCISCO, CA, 94108
• Phone: 415-661-1234

Officers, directors & promoters (1)

More

• CIK 2135564 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search